---
figid: PMC7054735__10.1177_2042018820904016-fig1
figlink: pmc/articles/PMC7054735/figure/fig1-2042018820904016/
number: F1
caption: Schematic representation of therapeutic approaches for osteogenesis imperfecta.
  (1) Bisphosphonates inhibit osteoclastic function. (2) Denosumab links RANKL, preventing
  the interaction with its receptor, RANK, on osteoclasts and osteoclasts precursors
  leading to inhibition of osteoclast formation and function. (3) Scl-Ab prevents
  binding of sclerostin to LRP5/6 and Frizzled coreceptors, thus inhibition of the
  Wnt/β-catenin signaling pathway. (4) Fresolimumab links TGF-β leading to beneficiary
  effects in bone remodeling. BPs, denosumab, and fresolimumab decrease bone resorption.
  Anti-sclerostin and fresolimumab increase bone formation.BPs, bisphosphonates; Fzld,
  Frizzled; HSC, hematopoietic stem cells; MSC, mesenchymal stroma cells; OPG, osteoprotegerin;
  RANK, receptor activator of nuclear factor κB; RANKL, receptor activator of nuclear
  factor κB ligand; Slc-Ab, sclerostin Antibodies; TGF-β, transforming growth factor-beta.
pmcid: PMC7054735
papertitle: New perspectives on the treatment of skeletal dysplasia.
reftext: Pauline Marzin, et al. Ther Adv Endocrinol Metab. 2020;11:2042018820904016.
pmc_ranked_result_index: '67430'
pathway_score: 0.9751198
filename: 10.1177_2042018820904016-fig1.jpg
figtitle: Therapeutic approaches for osteogenesis imperfecta
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7054735__10.1177_2042018820904016-fig1.html
  '@type': Dataset
  description: Schematic representation of therapeutic approaches for osteogenesis
    imperfecta. (1) Bisphosphonates inhibit osteoclastic function. (2) Denosumab links
    RANKL, preventing the interaction with its receptor, RANK, on osteoclasts and
    osteoclasts precursors leading to inhibition of osteoclast formation and function.
    (3) Scl-Ab prevents binding of sclerostin to LRP5/6 and Frizzled coreceptors,
    thus inhibition of the Wnt/β-catenin signaling pathway. (4) Fresolimumab links
    TGF-β leading to beneficiary effects in bone remodeling. BPs, denosumab, and fresolimumab
    decrease bone resorption. Anti-sclerostin and fresolimumab increase bone formation.BPs,
    bisphosphonates; Fzld, Frizzled; HSC, hematopoietic stem cells; MSC, mesenchymal
    stroma cells; OPG, osteoprotegerin; RANK, receptor activator of nuclear factor
    κB; RANKL, receptor activator of nuclear factor κB ligand; Slc-Ab, sclerostin
    Antibodies; TGF-β, transforming growth factor-beta.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNFSF11
  - TNFRSF11A
  - MSC
  - TNFRSF11B
  - FUT1
  - WNT1
  - WNT5A
  - WNT6
  - WNT7A
  - WNT8A
  - WNT8B
  - WNT10B
  - WNT2B
  - WNT16
  - WNT2
  - WNT3
  - WNT7B
  - WNT11
  - WNT9A
  - WNT9B
  - WNT4
  - WNT10A
  - WNT5B
  - WNT3A
  - TGFB1
  - TGFB2
  - TGFB3
  - LRP5
  - LRP6
  - CTNNB1
  - SOST
genes:
- word: RANKL
  symbol: RANKL
  source: hgnc_alias_symbol
  hgnc_symbol: TNFSF11
  entrez: '8600'
- word: RANK
  symbol: RANK
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF11A
  entrez: '8792'
- word: MSC
  symbol: MSC
  source: hgnc_symbol
  hgnc_symbol: MSC
  entrez: '9242'
- word: ОPG
  symbol: OPG
  source: hgnc_prev_symbol
  hgnc_symbol: TNFRSF11B
  entrez: '4982'
- word: HSC
  symbol: HSC
  source: hgnc_prev_symbol
  hgnc_symbol: FUT1
  entrez: '2523'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: Lrp5/6AFzid
  symbol: LRP5
  source: hgnc_symbol
  hgnc_symbol: LRP5
  entrez: '4041'
- word: Lrp5/6
  symbol: LRP5
  source: hgnc_symbol
  hgnc_symbol: LRP5
  entrez: '4041'
- word: Lrp5/6
  symbol: LRP6
  source: hgnc_symbol
  hgnc_symbol: LRP6
  entrez: '4040'
- word: B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: SOST
  symbol: SOST
  source: hgnc_symbol
  hgnc_symbol: SOST
  entrez: '50964'
chemicals: []
diseases: []
figid_alias: PMC7054735__F1
redirect_from: /figures/PMC7054735__F1
figtype: Figure
---
